Author

Marion Lenté

Biologie du cartilage, biotechnologie et télémédecine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

Catherine BaugéiD· 2 shared Eva Lhuissier· 2 shared Juliette Aury‐LandasiD· 2 shared Karim BoumédieneiD· 2 shared A. VeyssièreiD· 1 shared Anais Julien· 1 shared Benoı̂t BernayiD· 1 shared Lyess Allas· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersDevelopmental Biology

Catherine BaugéORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epigenetic Regulation of Chondrogenesis: JMJD3 and UTX as Key Targets for Gene-Modified Mesenchymal Stem Cell Therapy in Cartilage Tissue Engineering

Lyess Allas, Juliette Aury‐Landas, Quitterie Rochoux, Anais Julien, Eva Lhuissier, Marion Lenté, Sybille Brochard, A. Veyssière, Karim Boumédiene, Catherine Baugé

This study investigates the roles of JMJD3 and UTX in chondrogenesis using mesenchymal stem cells and finds JMJD3 is critical for cartilage formation while UTX is dispensable.

Molecular Therapy · Jan 21, 2026Peer-reviewedDevelopmental Biology

Exploring Adenosine Analogues for Chondrosarcoma Therapy: In Vitro and In Vivo Insights

Marion Lenté, Juliette Aury‐Landas, Mahdia Taieb, Benoı̂t Bernay, Eva Lhuissier, Karim Boumédiene, Catherine Baugé

This study evaluates adenosine analogues for chondrosarcoma treatment, finding that cladribine and clofarabine reduce cell viability and induce apoptosis in vitro and in vivo.

Molecular Therapy — Nucleic Acids · Jul 23, 2025Peer-reviewedCancer Biology